or Try an Advanced Search...

    Technical Analysis for NYXH - Nyxoah SA

    Grade Last Price % Change Price Change
    D 10.10 -3.16% -0.33
    NYXH closed down 3.16 percent on Friday, May 17, 2024, on 28 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: Jun 6
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical NYXH trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Calm After Storm Range Contraction -3.16%
    Wide Bands Range Expansion -3.16%
    Up 3 Days in a Row Strength -3.16%
    Up 4 Days in a Row Strength -3.16%
    Older End-of-Day Signals for NYXH ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 1 day ago
    Possible Inside Day 1 day ago
    Down 3% 1 day ago
    Down 2 % 1 day ago
    Down 1% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NYXH Chart by TradingView
    Basic chart:

    Profile

    Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Nyxoah’s team is driven by the vision that OSA sufferers should benefit from the latest and greatest innovations, for better health outcomes, higher patient comfort and quality of life. At the heart of Nyxoah’s innovation is a unique neurostimulation technology with more than 160 patents submitted worldwide.
    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Medicine Clinical Medicine Sleep Apnea Sleep Disorders Obstructive Sleep Apnea Neurostimulation Technology Osa

    Is NYXH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
    Apr 11 Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
    Mar 29 Information on the total number of voting rights and shares
    Mar 19 Nyxoah says Genio pivotal study meets primary endpoints
    Mar 19 Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
    Mar 7 Nyxoah S.A. (NASDAQ:NYXH) Q4 2023 Earnings Call Transcript
    Mar 5 Nyxoah S.A. (NYXH) Q4 2023 Earnings Call Transcript
    Mar 5 Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
    Mar 5 Nyxoah GAAP EPS of -$0.37 beats by $0.04, revenue of $1.83M misses by $0.12M
    Mar 5 Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
    See more NYXH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.0
    52 Week Low 4.0016
    Average Volume 43,678
    200-Day Moving Average 8.61
    50-Day Moving Average 11.86
    20-Day Moving Average 9.88
    10-Day Moving Average 9.33
    Average True Range 1.12
    RSI (14) 49.24
    ADX 18.61
    +DI 27.12
    -DI 17.67
    Chandelier Exit (Long, 3 ATRs) 8.85
    Chandelier Exit (Short, 3 ATRs) 11.54
    Upper Bollinger Bands 11.54
    Lower Bollinger Band 8.22
    Percent B (%b) 0.57
    BandWidth 33.62
    MACD Line -0.44
    MACD Signal Line -0.65
    MACD Histogram 0.2149
    Fundamentals Value
    Market Cap 289.61 Million
    Num Shares 28.7 Million
    EPS -1.81
    Price-to-Earnings (P/E) Ratio -5.58
    Price-to-Sales 94.38
    Price-to-Book 2.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.55
    Resistance 3 (R3) 10.58 10.47 10.47
    Resistance 2 (R2) 10.47 10.35 10.45 10.45
    Resistance 1 (R1) 10.28 10.28 10.22 10.25 10.42
    Pivot Point 10.17 10.17 10.14 10.15 10.17
    Support 1 (S1) 9.98 10.05 9.93 9.95 9.78
    Support 2 (S2) 9.87 9.98 9.85 9.75
    Support 3 (S3) 9.68 9.87 9.73
    Support 4 (S4) 9.65